“These findings support the hypothesis that serumcalcium is a prospective biomarker of fatal prostate cancer,” concluded researchers Halcyon G. Skinner, PhD, of the University of Wisconsin in Madison, and Gary G. Schwartz, PhD, MD, PhD, of Wake Forest University School of Medicine in Winston-Salem, N.C.
Men in the highest tertile of ionized serum calcium—the biologically active component of total serum calcium—were three times as likely as men in the lowest tertile to die from prostate cancer, the investigators reported. Men in the highest tertile of total serum calcium had a twofold increased risk of fatal prostate cancer, a finding that confirms previous research.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.